Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 21 - 30 out of 57

AMIA Outlines Priorities for NIH Data Science Strategy

April 3, 2018

In comments submitted yesterday, the American Medical Informatics Association (AMIA) called on the National Institutes of Health (NIH) to declare that all data generated through its grants align with FAIR data principles. It is not enough that the NIH commit to FAIR data principles, the nation’s experts in health and […]

AMIA Recommends Swift Implementation of Common Rule 2018 Requirements

March 19, 2018

In comments submitted to HHS March 19, 2018, AMIA recommended that HHS proceed swiftly with implementation of revisions to the Common Rule, known as the 2018 Requirements. AMIA recommended that 2018 Requirements be made effective July 19, 2018 and that the compliance date be set as January 19, 2019. This […]

AMIA Comments on CMS Innovation Center RFI

November 21, 2017

In response to a CMS Innovation Center request for information (RFI) on its potential new direction, AMIA offered several suggestions focusing on the interdependency of payment and delivery reforms, supported by health IT and health informatics. AMIA suggested additional guiding principles with which to approach new Innovation Center model design […]

AMIA Comments on NLM Data Science RFI

November 2, 2017

In response to a request for information (RFI) from the National Library of Medicine (NLM), AMIA detailed numerous key challenges and opportunities for data science in health and biomedicine. AMIA further provided policy and research ideas in support of the NLM fulfilling a 2015 Advisory Committee recommendation to become the […]

AMIA Response to NLM Strategic Plan

January 31, 2017

In comments submitted to the National Library of Medicine, AMIA said members envision a future where NLM leads the medical and research enterprise in demonstrating how real-world and “big” health data can be leveraged to develop new concepts of human disease, design novel therapies, and train future clinicians and researchers.

AMIA Response to PCORI Data Sharing Plan

January 24, 2017

In comments submitted to PCORI, AMIA voiced strong support for its draft Data Sharing Policy for awardees.  AMIA recommended that suggested that PCORI consider requiring a preliminary data sharing plan as part of award applications, and earmarking specified amounts of grant funding for data preparation and curation, among other recommendations.

AMIA Comments Regarding FDA’s Medical Device User Fee Agreement Letter (MDUFA IV)

November 2, 2016

In comments submitted to the FDA, AMIA voiced supported for several aspects of MDUFA IV meant to enhance use of consensus standards; develop patient engagement strategies and improve the science of patient input; utilize real world evidence (RWE) to improve regulatory decision-making; and development of a policy framework for Digital […]

AMIA Response to NIH RFI on Metrics to Assess Value of Biomedical Digital Repositories

October 5, 2016

In comments submitted September 29, AMIA recommend several ways the NIH could assess the value of biomedical digital repositories and knowledgebases.  The metrics span categories related to "utilization" and "impact" to "service quality" and "governance."  AMIA recommended another category be included relate to data quality and data completeness.